TipRanks
BB Biotech AG (DE:BBZA)
XETRA:BBZA
Germany Market
BBZA
BB Biotech
RESEARCH TOOLSreports

BB Biotech (BBZA) Income Statement

14 Followers

BB Biotech Income Statement

Last quarter (Q2 2026), BB Biotech's total revenue was CHF110.03M, a decrease of -217.42% from the same quarter last year. In Q2, BB Biotech's net income was CHF451.17M. See BB Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
CHF 76.81MCHF 111.63MCHF 35.00KCHF 4.00KCHF -396.22M
Gross Profit
CHF 76.76MCHF 111.63MCHF 35.00KCHF 4.00KCHF -396.22M
Operating Expenses
CHF -510.08MCHF 27.23MCHF 29.96MCHF 38.63MCHF 52.59M
Depreciation and Amortization
CHF 0.00CHF 0.00CHF 0.00CHF 0.00CHF 0.00
EBITDA
CHF 578.64MCHF 80.33MCHF -34.60MCHF -43.01MCHF -59.20M
Operating Income
CHF 586.83MCHF 84.40MCHF -29.93MCHF -38.62MCHF -52.59M
Other Income/Expenses
CHF -8.63MCHF -8.45MCHF -176.60MCHF -319.13MCHF -352.15M
Pretax Income
CHF 578.20MCHF 75.95MCHF -206.53MCHF -357.75MCHF -404.74M
Net Income
CHF 578.13MCHF 75.90MCHF -206.61MCHF -357.81MCHF -404.81M
Per Share Metrics
Basic EPS
CHF 10.54CHF 1.38CHF -3.77CHF -6.50CHF -7.31
Diluted EPS
CHF 10.54CHF 1.38CHF -3.77CHF -6.46CHF -7.31
Weighted Average Shares Outstanding
 54.85M 54.83M 54.80M 55.01M 55.36M
Weighted Average Shares Outstanding (Diluted)
 54.85M 54.83M 54.85M 55.36M 55.36M
Currency in CHF

BB Biotech Earnings and Revenue History